EVALUATION OF AMG 420, AN ANTI-BCMA BISPECIFIC T-CELL...

HemaSphere 2019 / 06 Vol. 3

EVALUATION OF AMG 420, AN ANTI-BCMA BISPECIFIC T-CELL ENGAGER (BITE®) IMMUNOTHERAPY, IN R/R MULTIPLE MYELOMA (MM) PATIENTS: UPDATED RESULTS OF A FIRST-IN-HUMAN (FIH) PHASE 1 DOSE ESCALATION STUDY

Topp, M., Duell, J., Zugmaier, G., Attal, M., Moreau, P., Langer, C., Kroenke, J., Facon, T., Salnikov, A., Lesley, R., Beutner, K., Kalabus, J., Rasmussen, E., Riemann, K., Minella, A., Munzert, G.,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
3
Journal:
HemaSphere
DOI:
10.1097/01.hs9.0000561580.66319.3d
Date:
June, 2019
File:
PDF, 294 KB
2019
Conversion to is in progress
Conversion to is failed